SEC Form 4 · accession 0001209191-18-053002
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edwin Hendrick
Officer — SVP, Chief Commercial Officer
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 2:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.75 | Sep 28, 2018 | A | 45,000 | A | — | Sep 27, 2028 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (9/28/19) with the balance vesting in equal monthly installments thereafter until fully vested on September 28, 2022.